儿童呼吸系统疾病:可实现的医疗质量基准更新
研究发现毛细支气管炎急诊中支气管扩张剂(19.7%)和胸片(14.4%)使用率低,肺炎窄谱抗生素使用率为57.3%,总体较既往报告有改善。
要点
- 建立了94项儿童呼吸系统疾病质量指标,可自动化提取行政数据。
- 毛细支气管炎急诊中支气管扩张剂使用率19.7%,胸片使用率14.4%。
- 肺炎窄谱抗生素使用率为57.3%,总体质量基准较前改善。
核心结论
- PRI报告提供了包括ABC在内的性能数据,并识别了常见呼吸系统疾病治疗质量中的差距。
研究设计与样本
- 多学科专家团队从多个来源选择质量指标,并应用于公共卫生信息系统数据库2017至2019年的急诊就诊和住院队列。
主要发现
- 毛细支气管炎急诊中支气管扩张剂使用率为19.7%,胸片使用率为14.4%。
- 住院队列中毛细支气管炎支气管扩张剂使用率为34.6%,胸片使用率为29.5%。
- 肺炎中窄谱抗生素使用率为57.3%。
- 总体而言,与既往报告相比,ABC向最佳性能有所改善。
关键数值与推荐
- 质量指标集共包含94项指标。
- 毛细支气管炎急诊支气管扩张剂使用率19.7%,胸片使用率14.4%。
- 住院毛细支气管炎支气管扩张剂使用率34.6%,胸片使用率29.5%。
- 肺炎窄谱抗生素使用率57.3%。
临床怎么用
- 可利用该自动化指标集监测儿童呼吸系统疾病医疗质量并识别性能差距。
局限性
- 未来方向包括检查健康不公平现象以及理解和应对COVID-19大流行对医疗质量的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVES: Pediatric respiratory illnesses (PRI): asthma, bronchiolitis, pneumonia, croup, and influenza are leading causes of pediatric hospitalizations, and emergency department (ED) visits in the United States. There is a lack of standardized measures to assess the quality of hospital care delivered for these conditions. We aimed to develop a measure set for automated data extraction from administrative data sets and evaluate its performance including updated achievable benchmarks of care (ABC). METHODS: A multidisciplinary subject-matter experts team selected quality measures from multiple sources. The measure set was applied to the Public Health Information System database (Children's Hospital Association, Lenexa, KS) to cohorts of ED visits and hospitalizations from 2017 to 2019. ABC for pertinent measures and performance gaps of mean values from the ABC were estimated. ABC were compared with previous reports. RESULTS: The measure set: PRI report includes a total of 94 quality measures. The study cohort included 984 337 episodes of care, and 82.3% were discharged from the ED. Measures with low performance included bronchodilators (19.7%) and chest x-rays (14.4%) for bronchiolitis in the ED. These indicators were (34.6%) and (29.5%) in the hospitalized cohort. In pneumonia, there was a 57.3% use of narrow spectrum antibiotics. In general, compared with previous reports, there was improvement toward optimal performance for the ABCs. CONCLUSIONS: The PRI report provides performance data including ABC and identifies performance gaps in the quality of care for common respiratory illnesses. Future directions include examining health inequities, and understanding and addressing the effects of the coronavirus disease 2019 pandemic on care quality.
引用
- Reyes MA, Etinger V, Hronek C, et al. Pediatric Respiratory Illnesses: An Update on Achievable Benchmarks of Care. Pediatrics. 2023. PMID: 37403624. doi:10.1542/peds.2022-058389
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。